Literature DB >> 31652350

Oral cancer-associated tertiary lymphoid structures: gene expression profile and prognostic value.

K Li1,2,3, Q Guo4, X Zhang5, X Dong5, W Liu6, A Zhang6, Y Li5, J Yan5, G Jia5, Z Zheng5, W Tang6, L Pan6, M An7, B Zhang2,3, S Liu1, B Fu6.   

Abstract

Tertiary lymphoid structure (TLS) provides a local and critical microenvironment for both cellular and humoral immunity and supports effective antigen presentation and lymphocyte activation. However, the gene expression profile and prognostic significance of TLS in oral cancer remain largely unrevealed. In this study, we found the presence of both intratumoral and peritumoral TLSs in a series of 65 patients with oral cancer treated by surgical resection, with positive detection rates of 33.8 and 75.4%, respectively. The presence of intratumoral TLSs, but not peritumoral TLSs, was significantly associated with decreased P53 and Ki67 scores (P = 0·027 and 0·047, respectively). The survival analyses revealed that oral cancer patients with higher grades of TLSs was associated with improved disease-free survival (DFS) and overall survival (OS) (P = 0·037 and 0·031, respectively). Gene expression profiling analysis of the cytokines and chemokines responsible for lymph-node neogenesis identified a three-up-regulated-gene set, i.e. IL7, LTB and CXCL13, which was shown to be correlated with human oral cancer-associated TLSs. This study provides a framework for better understanding of oral cancer-associated TLSs and for delineating future innovative prognostic biomarkers and immune therapeutic strategies for oral cancer.
© 2019 British Society for Immunology.

Entities:  

Keywords:  oral cancer; prognostic biomarker; tertiary lymphoid structure; therapeutic target

Mesh:

Substances:

Year:  2019        PMID: 31652350      PMCID: PMC6954676          DOI: 10.1111/cei.13389

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  40 in total

Review 1.  Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity.

Authors:  Victor H Engelhard; Anthony B Rodriguez; Ileana S Mauldin; Amber N Woods; J David Peske; Craig L Slingluff
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

2.  Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma.

Authors:  Julien Calderaro; Florent Petitprez; Etienne Becht; Alexis Laurent; Théo Z Hirsch; Benoit Rousseau; Alain Luciani; Giuliana Amaddeo; Jonathan Derman; Cécile Charpy; Jessica Zucman-Rossi; Wolf Herman Fridman; Catherine Sautès-Fridman
Journal:  J Hepatol       Date:  2018-09-11       Impact factor: 25.083

3.  Distinct Tertiary Lymphoid Structure Associations and Their Prognostic Relevance in HER2 Positive and Negative Breast Cancers.

Authors:  Xia Liu; Julia Y S Tsang; Thazin Hlaing; Jintao Hu; Yun-Bi Ni; Siu Ki Chan; Sai Yin Cheung; Gary M Tse
Journal:  Oncologist       Date:  2017-07-12

4.  Tertiary lymphoid structures: prognostic significance and relationship with tumour-infiltrating lymphocytes in triple-negative breast cancer.

Authors:  Hee Jin Lee; In Ah Park; In Hye Song; Su-Jin Shin; Joo Young Kim; Jong Han Yu; Gyungyub Gong
Journal:  J Clin Pathol       Date:  2015-10-16       Impact factor: 3.411

5.  Lymphoid aggregates in desmoplastic melanoma have features of tertiary lymphoid structures.

Authors:  Anne M Stowman; Alexandra W Hickman; Ileana S Mauldin; Adela Mahmutovic; Alejandro A Gru; Craig L Slingluff
Journal:  Melanoma Res       Date:  2018-06       Impact factor: 3.599

6.  Targeting Tertiary Lymphoid Structures for Tumor Immunotherapy.

Authors:  Haidong Tang; Xiangyan Qiu; Casey Timmerman; Yang-Xin Fu
Journal:  Methods Mol Biol       Date:  2018

Review 7.  The formation and function of tertiary lymphoid follicles in chronic pulmonary inflammation.

Authors:  Koshika Yadava; Paul Bollyky; Melissa A Lawson
Journal:  Immunology       Date:  2016-08-16       Impact factor: 7.397

8.  IL-7-producing stromal cells are critical for lymph node remodeling.

Authors:  Lucas Onder; Priyanka Narang; Elke Scandella; Qian Chai; Maria Iolyeva; Kerim Hoorweg; Cornelia Halin; Ellen Richie; Paul Kaye; Jürgen Westermann; Tom Cupedo; Mark Coles; Burkhard Ludewig
Journal:  Blood       Date:  2012-09-06       Impact factor: 22.113

9.  Bimodal Expansion of the Lymphatic Vessels Is Regulated by the Sequential Expression of IL-7 and Lymphotoxin α1β2 in Newly Formed Tertiary Lymphoid Structures.

Authors:  Saba Nayar; Joana Campos; Ming May Chung; Leyre Navarro-Núñez; Menka Chachlani; Nathalie Steinthal; David H Gardner; Philip Rankin; Thomas Cloake; Jorge H Caamaño; Helen M McGettrick; Steve P Watson; Sanjiv Luther; Christopher D Buckley; Francesca Barone
Journal:  J Immunol       Date:  2016-07-29       Impact factor: 5.422

10.  Induction of Tertiary Lymphoid Structures With Antitumor Function by a Lymph Node-Derived Stromal Cell Line.

Authors:  Genyuan Zhu; Satoshi Nemoto; Adam W Mailloux; Patricio Perez-Villarroel; Ryosuke Nakagawa; Rana Falahat; Anders E Berglund; James J Mulé
Journal:  Front Immunol       Date:  2018-07-16       Impact factor: 7.561

View more
  11 in total

Review 1.  Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies.

Authors:  Hua Zhao; Hao Wang; Qiuru Zhou; Xiubao Ren
Journal:  Cancer Biol Med       Date:  2021-09-24       Impact factor: 5.347

2.  Relationship between Tertiary Lymphoid Structure and the Prognosis and Clinicopathologic Characteristics in Solid Tumors.

Authors:  Zhan Zhao; Hui Ding; Zheng-Bin Lin; Sheng-Hui Qiu; Yi-Ran Zhang; Yan-Guan Guo; Xiao-Dong Chu; Loi I Sam; Jing-Hua Pan; Yun-Long Pan
Journal:  Int J Med Sci       Date:  2021-04-07       Impact factor: 3.738

3.  B cells and cancer: To B or not to B?

Authors:  Wolf Herman Fridman; Florent Petitprez; Maxime Meylan; Tom Wei-Wu Chen; Cheng-Ming Sun; Lubka T Roumenina; Catherine Sautès-Fridman
Journal:  J Exp Med       Date:  2021-01-04       Impact factor: 14.307

4.  Circular RNA circBCBM1 promotes breast cancer brain metastasis by modulating miR-125a/BRD4 axis.

Authors:  Bo Fu; Wei Liu; Cui Zhu; Peng Li; Li Wang; Li Pan; Ke Li; Peiying Cai; Min Meng; Yiting Wang; Anqi Zhang; Wenqiang Tang; Meng An
Journal:  Int J Biol Sci       Date:  2021-07-22       Impact factor: 6.580

Review 5.  Emerging concepts regarding pro- and anti tumor properties of B cells in tumor immunity.

Authors:  You Qin; Furong Lu; Kexing Lyu; Alfred E Chang; Qiao Li
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

6.  Tertiary lymphoid structures favor outcome in resected esophageal squamous cell carcinoma.

Authors:  Rutao Li; Xing Huang; Wenmin Yang; Jifan Wang; Yingkuan Liang; Te Zhang; Qixing Mao; Wenjie Xia; Lin Xu; Xinyu Xu; Gaochao Dong; Feng Jiang
Journal:  J Pathol Clin Res       Date:  2022-06-16

Review 7.  The neglected brothers come of age: B cells and cancer.

Authors:  Shabnam Shalapour; Michael Karin
Journal:  Semin Immunol       Date:  2021-06-29       Impact factor: 10.671

8.  Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma.

Authors:  Qunxing Li; Xiangqi Liu; Dikan Wang; Yanqiong Wang; Huanzi Lu; Shuqiong Wen; Juan Fang; Bin Cheng; Zhi Wang
Journal:  Int J Oral Sci       Date:  2020-09-15       Impact factor: 6.344

Review 9.  CXCL13 in Cancer and Other Diseases: Biological Functions, Clinical Significance, and Therapeutic Opportunities.

Authors:  San-Hui Gao; Sheng-Zhi Liu; Gui-Zhen Wang; Guang-Biao Zhou
Journal:  Life (Basel)       Date:  2021-11-23

Review 10.  Tumor-Associated Tertiary Lymphoid Structures: From Basic and Clinical Knowledge to Therapeutic Manipulation.

Authors:  Charlotte Domblides; Juliette Rochefort; Clémence Riffard; Marylou Panouillot; Géraldine Lescaille; Jean-Luc Teillaud; Véronique Mateo; Marie-Caroline Dieu-Nosjean
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.